Physician profile
Ann Langer
NPI 1427119841
$3,083.67
in general payments reported to CMS, 2019-2025
33 companies · $623 in 2025
The $623 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $184 · 2021: $271 · 2022: $826 · 2023: $527 · 2024: $340 · 2025: $623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $615.08 | 2021-2025 | |
| Astellas Pharma US INC | $394.46 | 2019-2025 | Veozah |
| Therapeuticsmd, INC. | $336.57 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $233.63 | 2021-2025 | |
| Organon LLC | $178.53 | 2022-2024 | Nexplanon, Nuvaring |
| Hologic Sales and Service, LLC | $165.73 | 2019-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $163.30 | 2022-2025 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $142.06 | 2019-2025 | |
| Evofem Biosciences, INC. | $79.32 | 2021-2022 | |
| Myovant Sciences INC. | $67.10 | 2022 | |
| Avion Pharmaceuticals | $66.35 | 2020-2023 | Balcoltra |
| Channel Medsystems, INC. | $64.67 | 2022 | |
| Millicent US INC | $61.61 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Scynexis, INC. | $52.10 | 2022 | |
| Sumitomo Pharma America, INC. | $44.51 | 2023-2024 | Myfembree |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $40.00 | 2019-2024 | |
| Exeltis, USA INC. | $36.43 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $28.79 | 2022 | |
| Biogen, INC. | $28.75 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $26.44 | 2019 | |
| Lupin INC. | $26.27 | 2019 | |
| Cook Medical LLC | $25.43 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $24.73 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.53 | 2024 | Jardiance |
| Baxter Healthcare | $20.88 | 2025 | Perclot |
| Merck Sharp & Dohme LLC | $20.56 | 2021 | |
| Ethicon US, LLC | $20.55 | 2023 | Megadyne, Stratafix, Surgicel Nu-Knit |
| Amgen INC. | $19.99 | 2019 | |
| Exact Sciences Corporation | $18.37 | 2023 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $17.31 | 2022 | |
| Gynesonics, INC. | $15.75 | 2022 | |
| Medtronic, INC. | $14.60 | 2023 | Truclear |
| Trevena, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Langer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.